Latest imported 13F data
โณ
Showing Q3 2025 data
HedgeTrack has imported Q4 2025 data overall, but Ikarian Capital, LLC's latest available filing here is Q3 2025.

Ikarian Capital, LLC

โ€ขCIK: 1778253โ€ขFiling: Q3 2025

**Ikarian Capital, LLC** manages $724M across a diversified portfolio of 139 positions. The fund exhibits significant concentration in select sectors, with XBI representing the largest holding at $75.2M. Notable allocations include GMAB at $53.0M and BMY at $36.1M, indicating targeted exposure across various market segments. This structure suggests a concentrated, actively managed approach to generating alpha.

Total AUM
$439.5M
+ $284.8M in options
QoQ Performance
+80.7%
Positions
108
+ 31 options
Top 10 Concentration
46.0%
Latest Filing
Q3 2025

Top Holdings Allocation

XBI
GMAB
XBI10.4%
GMAB7.3%
BMY5.0%
ABVX4.6%
UNIQURE4.3%
IONS3.7%
CDTX3.7%
MAZE2.7%

๐Ÿ“ˆ Biggest Buys

XBIPUT
SPDR SERIES TRUST
NEW
10.4% of portfolio
GMAB
GENMAB A/S
NEW
7.3% of portfolio
BMYPUT
BRISTOL-MYERS SQUIBB CO
NEW
5.0% of portfolio
ABVX
ABIVAX SA
NEW
4.6% of portfolio
IONS
IONIS PHARMACEUTICALS INC
NEW
3.7% of portfolio

๐Ÿ“‰ Biggest Sells

INSM
INSMED INC
-91.6%
0.3% of portfolio
โ€”CALL
UNIQURE NV
-33.1%
4.3% of portfolio
COGT
COGENT BIOSCIENCES INC
-98.9%
0.0% of portfolio
RAREPUT
ULTRAGENYX PHARMACEUTICAL IN
-83.6%
0.4% of portfolio
PRAX
PRAXIS PRECISION MEDICINES I
-89.7%
0.2% of portfolio

Sector Breakdown

Other95.0%
Healthcare5.0%

๐Ÿšช Exited Positionssold since Q2 2025

ALNY
ALNYLAM PHARMACEUTICALS INC
SOLD
$18.5M
VRNA
VERONA PHARMA PLC
SOLD
$13.9M
VERA
VERA THERAPEUTICS INC
SOLD
$3.6M
APGE
APOGEE THERAPEUTICS INC
SOLD
$3.4M
TECX
TECTONIC THERAPEUTIC INC
SOLD
$3.3M
+18 more exited positions

Changes from Q2 2025

NEW48 new positions
โ†‘28 increased
โ†“35 decreased

Historical Filings

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022